Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Future Medicinal Chemistry|January 19, 2017
Pseudokinases: update on their functions and evaluation as new drug targetsDominic P Byrne, Daniel M Foulkes, Patrick A EyersRSC Chemical Biology|June 27, 2025
Regulation of bacterial phosphorelay systemsDaniel M Foulkes, Daniel M Cooper, Catherine Westland, et al.Biochemical Society Transactions|October 31, 2015
Tribbles pseudokinases: novel targets for chemical biology and drug discovery?Daniel M Foulkes, Dominic P Byrne, Fiona P Bailey, et al.Plos One|April 3, 2025
Stable topical application of antimicrobials using plumbing rings in an ex vivo porcine corneal infection modelDaniel M Foulkes, Keri Mclean, Tarunima Sharma, et al.Microorganisms|January 1, 2020
Pseudomonas aeruginosa Toxin ExoU as a Therapeutic Target in the Treatment of Bacterial InfectionsDaniel M Foulkes, Keri McLean, Atikah S Haneef, et al.Rheumatology (Oxford, England)|August 13, 2025
Autophagy inhibitors block pathogenic NET release in immune-mediated inflammatory disease without impairing host defenceAndy Nolan, Daniel M Foulkes, Emma E Fairweather, et al.The Biochemical Journal|January 18, 2021
A pipeline to evaluate inhibitors of the Pseudomonas aeruginosa exotoxin UDaniel M Foulkes, Keri McLean, Yalin Zheng, et al.The Biochemical Journal|December 12, 2022
Impact of fluoroquinolones and aminoglycosides on P. aeruginosa virulence factor production and cytotoxicityDaniel M Foulkes, Keri McLean, Marta Sloniecka, et al.Plos Pathogens|August 3, 2026
Topical formulation of repurposed FDA-approved compounds inhibits Pseudomonas aeruginosa ExoU and improves corneal infection outcomesDaniel M Foulkes, David G Fernig, Keri McLean, et al.Science Signaling|September 27, 2018
Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cellsDaniel M Foulkes, Dominic P Byrne, Wayland Yeung, et al.Pageof 2